ADA 2026: Pharmacist CE Programs May Reduce Clinical Inertia In Type 2 Diabetes
New findings presented at the 2026 American Diabetes Association Scientific Sessions in New Orleans suggest that pharmacist continuing education programs may help reduce clinical inertia in type 2 diabetes. The findings point to a growing need for practical, pharmacist-led support when treatment goals are not being met. Clinical inertia remains a major concern in diabetes … Read more
